At the exhibition, products from the factories such as Aloe emodin and Sitagliptin intermediates garnered extensive attention and sparked insightful discussion. Recognizing the ongoing expansion of overseas markets and the evolving demands of customers, Sunrise is committed to intensifying its production layout of pharmaceutical intermediates and raw materials, thereby securing new avenues for growth. 

The exhibition served as a hub for numerous overseas customers who visited the Sunrise booth, engaging in profound discussions on market trends, industry policies, and expressing intentions for future collaborations. The business team meticulously analyzed the emerging demands and issues of customers, providing optimized solutions and laying the foundation for enduring win-win partnerships.